scispace - formally typeset
M

Manfred Blobner

Researcher at Technische Universität München

Publications -  211
Citations -  4801

Manfred Blobner is an academic researcher from Technische Universität München. The author has contributed to research in topics: Rocuronium & Sugammadex. The author has an hindex of 33, co-authored 193 publications receiving 4026 citations. Previous affiliations of Manfred Blobner include University of Ulm & University of Innsbruck.

Papers
More filters
Journal ArticleDOI

Early, goal-directed mobilisation in the surgical intensive care unit: a randomised controlled trial

Stefan J. Schaller, +20 more
- 01 Oct 2016 - 
TL;DR: Early, goal-directed mobilisation improved patient mobilisation throughout S ICU admission, shortened patient length of stay in the SICU, and improved patients' functional mobility at hospital discharge.
Journal ArticleDOI

The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats.

Kristin Engelhard, +7 more
- 01 Feb 2003 - 
TL;DR: It is possible that the neuroprotective properties of dexmedetomidine and S(+)-ketamine seen in previous studies involve ultra-early modulation of the balance between pro- and antiapoptotic proteins.
Journal ArticleDOI

Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study.

Eva Kirmeier, +865 more
- 01 Feb 2019 - 
TL;DR: It is shown that the use of neuromuscular blocking drugs in general anaesthesia is associated with an increased risk of postoperative pulmonary complications, and Anaesthetists must balance the potential benefits of neurmuscular blockade against the increasedrisk of postoperatively pulmonary complications.
Journal ArticleDOI

Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial

Manfred Blobner, +5 more
- 01 Oct 2010 - 
TL;DR: Sugammadex achieved significantly faster recovery of neuromuscular function after rocuronium to a TOF ratio of 0.9 compared with neostigmine (Clinicaltrials.gov identifier: NCT00451217).
Journal ArticleDOI

Plasma oxytocin and vasopressin do not predict neuropeptide concentrations in human cerebrospinal fluid.

Simone Maria Kagerbauer, +5 more
- 01 Jul 2013 - 
TL;DR: Although OXT and AVP levels in the CSF exceeded those in plasma, there was no correlation between both compartments, clearly suggesting that plasma OXT or AVP do not predict central neuropeptide concentrations.